As shown in Fig 5A–5C, in GBM samples collected prior to bevacizumab treatment (bevacizumab-responsive) Nrp1 protein was robustly expressed in tumor cells as well as in intratumoral blood vessels. The gene discussed is NRP1; the disease is glioblastoma.